Cited by 267Muscle Physiology and DisordersNutrition and Health in AgingMitochondrial Function and Pathology

Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia

Open access
Ibebunjo, Chikwendu, Chick, Joel M., Kendall, Tracee, Eash, John K., Li, Christine, Zhang, Yunyu, Vickers, Chad, Wu, Zhidan +14 more·2013·Molecular and Cellular Biology

Abstract

Molecular mechanisms underlying sarcopenia, the age-related loss of skeletal muscle mass and function, remain unclear. To identify molecular changes that correlated best with sarcopenia and might contribute to its pathogenesis, we determined global gene expression profiles in muscles of rats aged 6, 12, 18, 21, 24, and 27 months. These rats exhibit sarcopenia beginning at 21 months. Correlation of the gene expression versus muscle mass or age changes, and functional annotation analysis identified gene signatures of sarcopenia distinct from gene signatures of aging. Specifically, mitochondrial energy metabolism (e.g., tricarboxylic acid cycle and oxidative phosphorylation) pathway genes were the most downregulated and most significantly correlated with sarcopenia. Also, perturbed were genes/pathways associated with neuromuscular junction patency (providing molecular evidence of sarcopenia-related functional denervation and neuromuscular junction remodeling), protein degradation, and inflammation. Proteomic analysis of samples at 6, 18, and 27 months confirmed the depletion of mitochondrial energy metabolism proteins and neuromuscular junction proteins. Together, these findings suggest that therapeutic approaches that simultaneously stimulate mitochondrogenesis and reduce muscle proteolysis and inflammation have potential for treating sarcopenia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mcb.01036-12

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduction of the mitochondrial fusion machinery in muscle has been linked to age-related sarcopenia and metabolic diseases like obesity and type 2 diabetes in both rodents and humans.

    “Accordingly, the reduction of the mitochondrial fusion machinery in muscle has been linked to age-related sarcopenia [185–187], and metabolic diseases like obesity and type 2 diabetes [188, 189] in both rodents and humans.”
  • Muscle loss in aging sarcopenia, cancer cachexia, chemotherapy-induced cachexia, and in a model of myasthenia gravis is characterized by the decline of both fusion and fission machinery.

    “Muscle loss in aging sarcopenia [185, 187, 215], cancer cachexia, chemotherapy-induced cachexia [157–159], and in a model of myasthenia gravis [216], is characterized by the decline of both fusion and fission machinery.”
  • Muscle loss in aging sarcopenia, cancer cachexia, and myasthenia gravis is characterized by the decline of both fusion machinery and fission machinery.

    “However, muscle loss in aging sarcopenia, cancer cachexia, and myasthenia gravis are characterized by the decline of both fusion machinery and fission machinery [6,11,12,15,16,17,18].”
  • Both mRNA and protein abundance of important fusion and fission proteins are lower in old compared with young adult skeletal muscle.

    “both the mRNA level and the protein abundance of important fusion and fission proteins have been reported to be lower in old as compared to young adult skeletal muscle (55)”

    From Mitochondria initiate and regulate sarcopenia (2017) · cites this paper as [55]

  • Muscle mitochondria are important regulators of muscle size.

    “Together, these observations support for the idea that muscle mitochondria are important regulators of muscle size.”

    From Mitochondria initiate and regulate sarcopenia (2017) · cites this paper as [55]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ibebunjo, C., Chick, J. M., Kendall, T., Eash, J. K., Li, C., Zhang, Y., Vickers, C., Wu, Z., Clarke, B. A., Shi, J., Cruz, J., Fournier, B., Brachat, S., Gutzwiller, S., Ma, Q., Markovits, J., Broome, M., Steinkrauss, M., Skuba, E., Galarneau, J.-R., Gygi, S. P., & Glass, D. J.
Affiliations
  • Muscle Diseases Group, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
  • Harvard University (US)
  • Novartis Institutes for BioMedical Research (CH)
  • Cardiovascular and Metabolic Diseases, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
  • Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
  • Preclinical Safety Sciences, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
Venue
Molecular and Cellular Biology
Published
2013-01-01
Volume
33
Issue
2
Pages
194-212
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2097103188
Cited by
267
References
68
Citations by year
2026: 5 · 2025: 11 · 2024: 18 · 2023: 22 · 2022: 15 · 2021: 30 · 2020: 23 · 2019: 30 · 2018: 22 · 2017: 20 · 2016: 25 · 2015: 20 · 2014: 20 · 2013: 6
FWCI
5.88
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
sarcopenia, skeletal muscle aging, mitochondrial bioenergetics, oxidative phosphorylation, TCA cycle, neuromuscular junction, muscle protein degradation, muscle inflammation, gene expression profiling, proteomic profiling, mitochondrial dysfunction, rat model
MeSH terms
Aging, Animals, DNA, Mitochondrial, Energy Metabolism, Immunohistochemistry, Male, Mitochondria, Neuromuscular Junction, Postmortem Changes, Signal Transduction, Up-Regulation, Linear Models, Rats, Sprague-Dawley, Muscle, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Proteome, Gene Expression Profiling, Proteomics, Microarray Analysis, Rats, Muscle Strength, Sarcopenia, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review